Wells Fargo
TECX

Wells Fargo’s Tectonic Therapeutic TECX Stock Holding History

Wells Fargo’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.48M Sell
112,664
-7,747
-6% -$191K ﹤0.01% 2864
2025
Q4 		$2.51M Buy
120,411
+17,938
+18% +$333K ﹤0.01% 3260
2025
Q3 		$1.61M Buy
102,473
+29,701
+41% +$613K ﹤0.01% 3478
2025
Q2 		$1.45M Buy
72,772
+40,001
+122% +$811K ﹤0.01% 3465
2025
Q1 		$580K Buy
32,771
+14,258
+77% +$465K ﹤0.01% 3985
2024
Q4 		$855K Sell
18,513
-2,439
-12% -$103K ﹤0.01% 3814
2024
Q3 		$635K Buy
20,952
+11,227
+115% +$205K ﹤0.01% 3841
2024
Q2 		$160K Sell
9,725
-754
-7% -$12.1K ﹤0.01% 4653
2024
Q1 		$161K Sell
10,479
-726
-6% -$11.5K ﹤0.01% 4604
2023
Q4 		$183K Sell
11,205
-1,179
-10% -$20.2K ﹤0.01% 4515
2023
Q3 		$229K Sell
12,384
-1,541
-11% -$27.2K ﹤0.01% 4272
2023
Q2 		$159K Buy
13,925
+2,503
+22% +$28.3K ﹤0.01% 4727
2023
Q1 		$137K Buy
11,422
+3,967
+53% +$55.2K ﹤0.01% 4653
2022
Q4 		$63.8K Sell
7,455
-462
-6% -$4.07K ﹤0.01% 4754
2022
Q3 		$61K Buy
7,917
+375
+5% +$4.16K ﹤0.01% 4860
2022
Q2 		$83K Buy
7,542
+78
+1% +$919 ﹤0.01% 4753
2022
Q1 		$118K Sell
7,464
-198
-3% -$4.09K ﹤0.01% 5238
2021
Q4 		$354K Buy
7,662
+2,787
+57% +$160K ﹤0.01% 4937
2021
Q3 		$327K Sell
4,875
-316
-6% -$25.9K ﹤0.01% 4895
2021
Q2 		$554K Sell
5,191
-925
-15% -$110K ﹤0.01% 4564
2021
Q1 		$931K Sell
6,116
-417
-6% -$67.8K ﹤0.01% 4297
2020
Q4 		$1.09M Buy
6,533
+4,756
+268% +$845K ﹤0.01% 3965
2020
Q3 		$278K Sell
1,777
-3,523
-66% -$710K ﹤0.01% 4768
2020
Q2 		$1.11M Buy
5,300
+2,834
+115% +$584K ﹤0.01% 3729
2020
Q1 		$460K Buy
2,466
+467
+23% +$110K ﹤0.01% 4100
2019
Q4 		$483K Sell
1,999
-1,436
-42% -$277K ﹤0.01% 4405
2019
Q3 		$583K Buy
3,435
+1,389
+68% +$314K ﹤0.01% 4258
2019
Q2 		$400K Buy
2,046
+1,260
+160% +$272K ﹤0.01% 4536
2019
Q1 		$208K Sell
786
-28,764
-97% -$5.26M ﹤0.01% 4801
2018
Q4 		$5.9M Sell
29,550
-1,079
-4% -$329K ﹤0.01% 2286
2018
Q3 		$19.1M Buy
+30,629
New +$13.6M 0.01% 1529

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Wells Fargo's TECX Position: Q1 2026 in Review

Wells Fargo reduced its Tectonic Therapeutic (TECX) stake by 6.4% in Q1 2026, selling an estimated $191K and leaving 112,664 shares worth $3.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2864.

Wells Fargo first reported a position in TECX in Q3 2018 and has held it in 31 quarters since. The position peaked at $19.1M in Q3 2018. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

  • Wells Fargo held 112,664 shares of Tectonic Therapeutic worth $3.48M as of Q1 2026.
  • Wells Fargo sold 7,747 Tectonic Therapeutic shares in Q1 2026, an estimated $191K.
  • Tectonic Therapeutic made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2864 holding.
  • Wells Fargo first reported a position in Tectonic Therapeutic in Q3 2018 and has held it in 31 quarters since.
  • Wells Fargo's Tectonic Therapeutic position peaked at $19.1M in Q3 2018.
  • 111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.